Complete guide to understand and profit from PE investments in healthcare and life sciences

Private Equity in Healthcare and Life Sciences delves into the exciting world of private equity (PE) in health—products and services, life sciences and healthcare services—reviewing everything from the origins and types of funds to the stages of the investment process and financial modelling. This book explores how private equity integrates multiple disciplines and is thus even more an “art” than a science, combining strategy and economic operations to deliver a comprehensive approach to business success.

Leveraging the authors’ decades of experience advising investors and executives in healthcare, developing case studies and teaching PE across four continents, this book includes insights on:

• PE’s role in emerging health markets and the resilience of healthcare investments through various economic crises
• Deep discussions of conflicts between stakeholders
• Specificities of company valuation in the PE context
• A comprehensive list of strategies of value creation and two brand new frameworks that are presented
• How private equity funds work: who runs them, how they make money, how they are set up and structured and what drives and constrains their investment decisions
• Key investment trends in healthcare and life sciences, exploring why the sector has been attractive to private equity firms and how different investment models have evolved over time

Private Equity in Healthcare and Life Sciences is a key asset for both students interested in private equity, and all professionals working in healthcare and life sciences - medical staff, practice owners and medical and pharmaceutical managers who want to link their activities in healthcare with private equity. Whether they plan to raise funds, to sell their practice, or to join a portfolio company as a manager or an operating partner, this book will be an essential resource.

MARC KITTEN is a visiting Professor of Finance at Imperial Business School in London and a founding partner at Candesic, a leading strategy consultancy focused on healthcare and life sciences. He has advised on several hundred transactions and holds an MBA from Chicago Booth.

GILLES CHEMLA, PHD, is a Professor of Finance at Imperial Business School and Co-director of Imperial’s Centre for Financial Technology. He holds a PhD in economics from the London School of Economics.